Atlas Trials

Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

Clinical trial NCT04662112 · COMPLETED

Trial details

NCT number
NCT04662112
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Start date
2021-06-15
Primary completion
2023-10-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.